These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 37270444)
21. In vitro antifungal activity and toxicity of itraconazole in DMSA-PLGA nanoparticles. Cunha-Azevedo EP; Silva JR; Martins OP; Siqueira-Moura MP; Bocca AL; Felipe MS; Tedesco AC; Azevedo RB J Nanosci Nanotechnol; 2011 Mar; 11(3):2308-14. PubMed ID: 21449386 [TBL] [Abstract][Full Text] [Related]
22. Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. Kim JK; Park JS; Kim CK Int J Pharm; 2010 Jan; 383(1-2):209-15. PubMed ID: 19747966 [TBL] [Abstract][Full Text] [Related]
23. Formulation and characterization of biocompatible and stable I.V. itraconazole nanosuspensions stabilized by a new stabilizer polyethylene glycol-poly(β-Benzyl-l-aspartate) (PEG-PBLA). Zong L; Li X; Wang H; Cao Y; Yin L; Li M; Wei Z; Chen D; Pu X; Han J Int J Pharm; 2017 Oct; 531(1):108-117. PubMed ID: 28830781 [TBL] [Abstract][Full Text] [Related]
24. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Mukherjee S; Ray S; Thakur RS Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221 [TBL] [Abstract][Full Text] [Related]
25. Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. DiNunzio JC; Miller DA; Yang W; McGinity JW; Williams RO Mol Pharm; 2008; 5(6):968-80. PubMed ID: 19434851 [TBL] [Abstract][Full Text] [Related]
26. Encapsulating insoluble antifungal drugs into oleic acid-modified silica mesocomposites with enhanced fungicidal activity. Zhu P; Zhou L; Song Y; Cai L; Ji M; Wang J; Ruan G; Chen J J Mater Chem B; 2020 Jun; 8(22):4899-4907. PubMed ID: 32314756 [TBL] [Abstract][Full Text] [Related]
27. Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution. Wang J; Huang G Drug Deliv; 2011 Nov; 18(8):631-8. PubMed ID: 22111976 [TBL] [Abstract][Full Text] [Related]
28. Design and Evaluation of Eudragit RS-100 Based Itraconazole Nanosuspension for Ophthalmic Application. Pawar P; Duduskar A; Waydande S Curr Drug Res Rev; 2021; 13(1):36-48. PubMed ID: 32990554 [TBL] [Abstract][Full Text] [Related]
29. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability. Miller MA; DiNunzio J; Matteucci ME; Ludher BS; Williams RO; Johnston KP Drug Dev Ind Pharm; 2012 May; 38(5):557-70. PubMed ID: 21961961 [TBL] [Abstract][Full Text] [Related]
30. Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition. Miller DA; DiNunzio JC; Yang W; McGinity JW; Williams RO Drug Dev Ind Pharm; 2008 Aug; 34(8):890-902. PubMed ID: 18608468 [TBL] [Abstract][Full Text] [Related]
31. Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption. Sun W; Mao S; Shi Y; Li LC; Fang L J Pharm Sci; 2011 Aug; 100(8):3365-3373. PubMed ID: 21520089 [TBL] [Abstract][Full Text] [Related]
32. New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis. Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K Int J Nanomedicine; 2012; 7():5475-89. PubMed ID: 23093903 [TBL] [Abstract][Full Text] [Related]
33. Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles. Chen W; Zhan C; Gu B; Meng Q; Wang H; Lu W; Hou H J Drug Target; 2011 Apr; 19(3):228-34. PubMed ID: 20540685 [TBL] [Abstract][Full Text] [Related]
34. Itraconazole-loaded microemulsions: formulation, characterization, and dermal delivery using shed snakeskin as the model membrane. Promjan S; Boonme P Pharm Dev Technol; 2023 Jan; 28(1):51-60. PubMed ID: 36547258 [TBL] [Abstract][Full Text] [Related]
35. Amorphization strategy affects the stability and supersaturation profile of amorphous drug nanoparticles. Cheow WS; Kiew TY; Yang Y; Hadinoto K Mol Pharm; 2014 May; 11(5):1611-20. PubMed ID: 24669821 [TBL] [Abstract][Full Text] [Related]
36. Fabrication and characterization of zein nanoparticles by dextran sulfate coating as vehicles for delivery of curcumin. Yuan Y; Li H; Zhu J; Liu C; Sun X; Wang D; Xu Y Int J Biol Macromol; 2020 May; 151():1074-1083. PubMed ID: 31739020 [TBL] [Abstract][Full Text] [Related]
37. SUBA-itraconazole in the treatment of systemic fungal infections. Liu J; Vanderwyk KA; Donnelley MA; Thompson Iii GR Future Microbiol; 2024 Sep; 19(13):1171-1175. PubMed ID: 39011995 [TBL] [Abstract][Full Text] [Related]
38. Fabrication of Luteolin Loaded Zein-Caseinate Nanoparticles and its Bioavailability Enhancement in Rats. Xu QT; Zhang WX; Xu HX; Zhang QF J Pharm Sci; 2023 Dec; 112(12):3056-3066. PubMed ID: 37356712 [TBL] [Abstract][Full Text] [Related]
39. Formation, structural characterization, stability and in vitro bioaccessibility of 7,8-dihydroxyflavone loaded zein-/sophorolipid composite nanoparticles: effect of sophorolipid under two blending sequences. Chen Y; Xia G; Zhao Z; Xue F; Chen C; Zhang Y Food Funct; 2020 Feb; 11(2):1810-1825. PubMed ID: 32057043 [TBL] [Abstract][Full Text] [Related]
40. Optimization of valencene containing lipid vesicles for boosting the transungual delivery of itraconazole. Hoda Q; Aqil M; Ahad A; Imam SS; Praveen A; Qadir A; Iqbal Z 3 Biotech; 2021 Mar; 11(3):137. PubMed ID: 33708461 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]